Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus
Open Access
- 18 May 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 224 (1), 209-222
- https://doi.org/10.1007/s00213-012-2741-x
Abstract
Rationale It has been suggested that there are causal relationships between alterations in brain glia and major depression. Objectives To investigate whether a depressive-like state induces changes in brain astrocytes, we used chronic social stress in male rats, an established preclinical model of depression. Expression of two astrocytic proteins, the intermediate filament component glial fibrillary acidic protein (GFAP) and the cytoplasmic protein N-myc downregulated gene 2 (NDRG2), was analyzed in the hippocampus. For comparison, expression of the neuronal protein syntaxin-1A was also determined. Methods Adult male rats were subjected to daily social defeat for 5 weeks and were concomitantly treated with citalopram (30 mg/kg/day, via the drinking water) for 4 weeks. Results Western blot analysis showed that the chronic stress downregulated GFAP but upregulated NDRG2 protein. Citalopram did not prevent these stress effects, but the antidepressant per se downregulated GFAP and upregulated NDRG2 in nonstressed rats. In contrast, citalopram prevented the stress-induced upregulation of the neuronal protein syntaxin-1A. Conclusions These data suggest that chronic stress and citalopram differentially affect expression of astrocytic genes while the antidepressant drug does not prevent the stress effects. The inverse regulation of the cytoskeletal protein GFAP and the cytoplasmic protein NDRG2 indicates that the cells undergo profound metabolic changes during stress and citalopram treatment. Furthermore, the present findings indicate that a 4-week treatment with citalopram does not restore normal glial function in the hippocampus, although the behavior of the animals was normalized within this treatment period, as reported previously.This publication has 86 references indexed in Scilit:
- The stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionNature Reviews Neuroscience, 2011
- Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein βJournal of Neuroinflammation, 2011
- N-myc Downstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPaseJournal of Biological Chemistry, 2011
- Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivityJournal of Chemical Neuroanatomy, 2011
- Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Glial and glutamatergic markers in depression, alcoholism, and their comorbidityJournal of Affective Disorders, 2010
- Fates-shifted is an F-box protein that targets Bicoid for degradation and regulates developmental fate determination in Drosophila embryosNature, 2010
- Drug screening to identify suppressors of GFAP expressionHuman Molecular Genetics, 2010
- NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factorsThe Journal of Physiology, 2009
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzoleMolecular Psychiatry, 2008